Phase
Condition
Organ Transplant
Soft Tissue Infections
Inflammation
Treatment
Esketamine hydrochloride
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 years old ≤ age ≤60 years old;
SOFA score ≥2;
Mechanical ventilation should be required for at least 24 hours when included in thestudy;
Informed consent is obtained.
Exclusion
Exclusion Criteria:
Age < 18 years old or ≥ 60 years old;
Previous solid organ or bone marrow transplantation;
Autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.), orhematologic malignancies (leukemia and lymphoma, etc.);
Received radiotherapy or chemotherapy within the past 30 days, or receivedimmunosuppressant drugs (tripterygium wilfordii, mycophenolate mofetil,cyclophosphamide, FK506, etc.), or continuous treatment with prednisolone more than 10 mg/day (or equivalent doses of the other hormones);
Unstable angina pectoris or myocardial infarction in the past six months;
Acute brain injury (traumatic brain injury, subarachnoid hemorrhage, acute ischemicstroke, acute intracranial hemorrhage, acute intracranial infection, etc.);
Poorly controlled hypertension and congestive heart failure;
Increased intraocular or intracranial pressure;
Chronic kidney disease, received continuous renal replacement therapy in the past 30days, or acute renal failure requiring CRRT;
Severe chronic liver disease (Child-Pugh class B or C);
Alcohol dependence, mental illness or severe cognitive impairment;
Pregnancy or lactation;
Informed consent is not obtained.
Study Design
Connect with a study center
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei 430022
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.